Interplay of Oxidative Stress and Autophagy in PAMAM Dendrimers-Induced Neuronal Cell Death
Overview
Authors
Affiliations
Poly-amidoamine (PAMAM) dendrimers are proposed to be one of the most promising drug-delivery nanomaterials. However, the toxicity of PAMAM dendrimers on the central nervous system seriously hinders their medical applications. The relationship between oxidative stress and autophagy induced by PAMAM dendrimers, and its underlying mechanism remain confusing. In this study, we reported that PAMAM dendrimers induced both reactive oxygen species and autophagy flux in neuronal cells. Interestingly, autophagy might be triggered by the formation of reactive oxygen species induced by PAMAM dendrimers. Suppression of reactive oxygen species could not only impair PAMAM dendrimers-induced autophagic effects, but also reduce PAMAM dendrimers-induced neuronal cell death. Moreover, inhibition of autophagy could protect against PAMAM dendrimers-induced neuronal cell death. These findings systematically elucidated the interplay between oxidative stress and autophagy in the neurotoxicity of PAMAM dendrimers, which might encourage the application of antioxidants and autophagy inhibitors to ameliorate the neurotoxicity of PAMAM dendrimers in clinic.
Nanotherapeutics targeting autophagy regulation for improved cancer therapy.
Liu Y, Wang Y, Zhang J, Peng Q, Wang X, Xiao X Acta Pharm Sin B. 2024; 14(6):2447-2474.
PMID: 38828133 PMC: 11143539. DOI: 10.1016/j.apsb.2024.03.019.
The impact of nanomaterials on autophagy across health and disease conditions.
Florance I, Cordani M, Pashootan P, Moosavi M, Zarrabi A, Chandrasekaran N Cell Mol Life Sci. 2024; 81(1):184.
PMID: 38630152 PMC: 11024050. DOI: 10.1007/s00018-024-05199-y.
Autophagy-modulating biomaterials: multifunctional weapons to promote tissue regeneration.
Wu Y, Li L, Ning Z, Li C, Yin Y, Chen K Cell Commun Signal. 2024; 22(1):124.
PMID: 38360732 PMC: 10868121. DOI: 10.1186/s12964-023-01346-3.
Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer's Disease.
Moreira D, Santos S, Leiro V, Pego A Pharmaceutics. 2023; 15(4).
PMID: 37111540 PMC: 10140951. DOI: 10.3390/pharmaceutics15041054.
Zhang F, Zhang Z, Alt J, Kambhampati S, Sharma A, Singh S J Control Release. 2023; 358:27-42.
PMID: 37054778 PMC: 10330216. DOI: 10.1016/j.jconrel.2023.04.017.